Strong Revenue and EBITDA Growth
First quarter 2025 net operating revenues were $5.2 billion with consolidated adjusted EBITDA of $1.163 billion, representing a 14% growth over 2024.
Improved EBITDA Margins
Adjusted EBITDA margin improved by 320 basis points to 22.3% in the first quarter of 2025.
USPI Segment Performance
USPI delivered $56 million in adjusted EBITDA, a 16% growth, with a 6.8% increase in same facility system-wide revenues.
Hospital Segment Growth
Adjusted EBITDA for the hospital segment grew 12% to $707 million, with same store hospital admissions up 4.4% and revenue per adjusted admission up 2.8%.
Capital Deployment and Balance Sheet Management
Net debt to EBITDA minus NCI ratio was 3.1, with plans to invest $250 million annually in ambulatory M&A and a $348 million share repurchase.
Significant Free Cash Flow Generation
Generated $642 million of free cash flow in the first quarter, with $3 billion in cash on hand and no significant debt maturities until 2027.